CSIMarket
 


Nano x Imaging Ltd  (NNOX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

NNOX's Revenue Growth by Quarter and Year

Nano X Imaging Ltd's Revenue results by quarter and year




NNOX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 9.91 8.58 1.30 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   9.91 8.58 1.30 0.00



NNOX Revenue fourth quarter 2023 Y/Y Growth Comment
Nano x Imaging Ltd reported Revenue increase of 15.44% year on year in the fourth quarter 2023, to $ 9.91 millions, this is lower than Nano X Imaging Ltd's recent average Revenue surge of 557.82%.

According to the results reported in the fourth quarter 2023, Nano X Imaging Ltd achieved the best Revenue growth in Medical Laboratories industry. While Nano X Imaging Ltd' s Revenue growth of 15.44% ranks overall at the positon no. 23 in the fourth quarter 2023.




NNOX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 15.44 % 560 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   15.44 % 560 % - -

Financial Statements
Nano X Imaging Ltd's fourth quarter 2023 Revenue $ 9.91 millions NNOX's Income Statement
Nano X Imaging Ltd's fourth quarter 2022 Revenue $ 8.58 millions Quarterly NNOX's Income Statement
New: More NNOX's historic Revenue Growth >>


NNOX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   15.44 % 560 % - -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #5
Overall #23

Revenue Y/Y Growth Statistics
High Average Low
557.82 % 557.82 % 557.82 %
(Dec 31 2022)  
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #5
Overall #23
Revenue Y/Y Growth Statistics
High Average Low
557.82 % 557.82 % 557.82 %
(Dec 31 2022)  

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nano X Imaging Ltd's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NNOX's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NNOX's IV. Quarter Q/Q Revenue Comment


Nano X Imaging Ltd's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
0
Cumulative Revenue 12 Months Ending $ 9.91 $ 8.58 $ 0.00 $ 1.30 $ 0.00
Y / Y Revenue Growth (TTM) 15.47 % 557.82 % - - -
Year on Year Revenue Growth Overall Ranking # 23 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 15.47 % 557.82 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 23 # 0 # 0 # 0 # 0




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2023 period, Nano X Imaging Ltd's cumulative twelve months Revenue were $ 10 millions, company would post below average annual Revenue growth of 557.82% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Nano X Imaging Ltd's Revenue growth from the 0% growth in Dec 31 2022. Despite that, Nano X Imaging Ltd showed the highest Revenue growth, among it's peers in Medical Laboratories industry.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 23.

Revenue TTM Q/Q Growth Statistics
High Average Low
557.82 %
557.82 %
557.82 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 5
Overall # 23

Revenue TTM Y/Y Growth Statistics
High Average Low
557.82 %
557.82 %
557.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 5
S&P 500 # 23
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2023 period, Nano X Imaging Ltd's cumulative twelve months Revenue were $ 10 millions, company would post below average annual Revenue growth of 557.82% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Nano X Imaging Ltd's Revenue growth from the 0% growth in Dec 31 2022. Despite that, Nano X Imaging Ltd showed the highest Revenue growth, among it's peers in Medical Laboratories industry.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 23.

Revenue TTM Q/Q Growth Statistics
High Average Low
557.82 %
557.82 %
557.82 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 5
Overall # 23

Revenue TTM Y/Y Growth Statistics
High Average Low
557.82 %
557.82 %
557.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 5
S&P 500 # 23




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NNOX's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NNOX's Competitors
Revenue Growth for Nano X Imaging Ltd's Suppliers
Revenue Growth for NNOX's Customers

You may also want to know
NNOX's Annual Growth Rates NNOX's Profitability Ratios NNOX's Asset Turnover Ratio NNOX's Dividend Growth
NNOX's Roe NNOX's Valuation Ratios NNOX's Financial Strength Ratios NNOX's Dividend Payout Ratio
NNOX's Roa NNOX's Inventory Turnover Ratio NNOX's Growth Rates NNOX's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Dexcom Inc 26.94%$ 26.938 millions
Halozyme Therapeutics Inc 26.75%$ 26.746 millions
Medpace Holdings Inc 26.47%$ 26.466 millions
Pulmonx Corporation26.12%$ 26.120 millions
Maxcyte inc 26.09%$ 26.087 millions
Progyny Inc 26.04%$ 26.045 millions
United Therapeutics Corporation25.07%$ 25.066 millions
Neurocrine Biosciences Inc 25.05%$ 25.049 millions
Aquestive Therapeutics Inc 23.63%$ 23.629 millions
Sotera Health Company23.61%$ 23.612 millions
Xoma Corporation23.35%$ 23.351 millions
Vericel Corporation23.35%$ 23.346 millions
Inari Medical Inc 22.95%$ 22.949 millions
Exact Sciences Corporation22.81%$ 22.810 millions
Veracyte Inc 22.29%$ 22.295 millions
Guardant Health Inc 22.19%$ 22.195 millions
Cytek Biosciences Inc 22.06%$ 22.058 millions
Apyx Medical Corporation21.80%$ 21.798 millions
Alpha Pro Tech Ltd 21.78%$ 21.783 millions
Protalix Biotherapeutics inc 21.69%$ 21.690 millions
Si bone inc 21.28%$ 21.278 millions
Olink Holding Ab publ 21.18%$ 21.175 millions
Ensign Group Inc21.10%$ 21.104 millions
Aadi Bioscience Inc 21.03%$ 21.025 millions
Privia Health Group Inc 20.97%$ 20.966 millions
Biotricity Inc 20.89%$ 20.893 millions
Atricure Inc 20.52%$ 20.517 millions
Biomarin Pharmaceutical Inc20.22%$ 20.216 millions
Orthopediatrics Corp19.87%$ 19.872 millions
Amgen Inc 19.84%$ 19.842 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com